A Prospective, Epidemiologic and Multicentre Trial to Determine the Cardiovascular Risk, New Cardiovascular Events and the Cardiovascular Diseases in HIV-infected Patients: 15 Year Follow up

Recruiting

• Conditions: B24; I25; Unspecified human immunodeficiency virus [HIV] disease; Chronic ischaemic heart disease

• Registration Number: DRKS00021033
• Lead Sponsor: niversitätsklinikum Essen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-04-02
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 2000

Inclusion Criteria

Age > 18 Years
- diagnosed HIV-Infection
- Signed inform consent

Exclusion Criteria

- acute heart failure or cardiovascular event within the last 3 weeks before inclusion
-Pregnancy
- new AIDS-defining illness within the last 3 weeks before inclusion

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Cardiovascular Diseases in HIV-infected Patients

Secondary Outcome Measures

Name	Time	Method
Impact of classic cardiovascular risk factors of coronary artery disease, comorbidities and antiretroviral therapy